Fol. Biol. 2014, 60, 83-88
https://doi.org/10.14712/fb2014060020083
MTHFR and HFE, but Not Preproghrelin and LBP, Polymorphisms as Risk Factors for All-Cause End-Stage Renal Disease Development
References
1. , S., Tripathi, G., Khan, F., Sharma, R., Babruraj, V. P. (2007) Relationship between GSTs gene polymorphism and susceptibility to end stage renal disease among North Indians. Ren. Fail. 29, 947-953.
<https://doi.org/10.1080/08860220701641314>
2. , H., Koc, M., Sari, H., Tuglular, S., Ozener, C., Akoglu, E. (2007) Associations between apolipoprotein E gene poly- morphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients. Ren. Fail. 29, 713-719.
<https://doi.org/10.1080/08860220701460129>
3. , V. S., Rao, M. (2007) Genetic and reverse epidemiology among patients on chronic haemodialysis. Semin. Dial. 20, 570-576.
<https://doi.org/10.1111/j.1525-139X.2007.00361.x>
4. , R. C., O’Keefe, G. E. (2003) Characterization of a single nucleotide polymorphism in the lipopolysaccharide binding protein and its association with sepsis. Am. J. Respir. Crit. Care Med. 167, 1316-1320.
<https://doi.org/10.1164/rccm.200209-1064OC>
5. , C. (2003) The effect of convection on the nutritional status of haemodialysis patients. Nephrol. Dial. Transplant. 18 (Suppl. 7), vii46-vii49.
<https://doi.org/10.1093/ndt/gfg1079>
6. , S., Kuthanová, L., Hubáček, J. A. (2011) Poly- morphisms in IFN-γ, TNF-α and IL-10 in patients on maintenance haemodialysis. Folia Biol. (Praha) 57, 30-34.
7. , E., Alferi, C., Pelusi, S., Valenti, L. (2012) Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease. World J. Nephrol. 1, 166-176.
<https://doi.org/10.5527/wjn.v1.i6.166>
8. , C. C., Hung, C. H., Yen, C. S., Hwang, K. L., Lin, C. Y. (2005) The relationship of plasma ghrelin level to energy regulation, feeding and left ventricular function in nondiabetic haemodialysis patients. Nephrol. Dial. Transplant. 20, 2172-2177.
<https://doi.org/10.1093/ndt/gfi011>
9. , M., Půtová, I., Provazníková, H., Pintérová, D., Horák, J. (2005) S65C and other mutations in the haemochromatosis gene in the Czech population. Folia Biol. (Praha) 51, 172-176.
10. , T., Antoniadi, G., Liakopoulos, V., Kartsios, C., Stefanidis, I. (2007) Disturbances of acquired immunity in hemodialysis patients. Semin. Dial. 205, 440-451.
<https://doi.org/10.1111/j.1525-139X.2007.00283.x>
11. , J. V., Jayasena, C. N., Bloom, S. R. (2008) Gut hormones: a weight off your mind. J. Neuroendocrinol. 20, 834-841.
<https://doi.org/10.1111/j.1365-2826.2008.01729.x>
12. , M., Heine, G. H., Ulrich, C., Köhler, H., DialGene Consortium (2007) Gene polymorphism association studies in dialysis: vascular access. Semin. Dial. 20, 63-67.
<https://doi.org/10.1111/j.1525-139X.2007.00243.x>
13. , J. A., Stuber, F., Frohlich, D., Book, M. Wetegrove, S., Ritter, M., Rothe, G., Schmitz, G. (2001) Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit. Care Med. 29, 557-561.
<https://doi.org/10.1097/00003246-200103000-00015>
14. , J. A., Bohuslavova, R., Skodova, Z., Adamkova, V. (2007) Variants within the ghrelin gene – association with HDL-cholesterol, but not with body mass index. Folia Biol. (Praha) 53, 202-206.
15. , J.A., Viklicky, O., Dlouha, D., Bloudickova, S., Kubinova, R., Peasey, A., Pikhart, H., Adamkova, V., Brabcova, I., Pokorna, E., Bobak, M. (2012) The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population. Nephrol. Dial. Transplant. 27, 1030-1035.
<https://doi.org/10.1093/ndt/gfr418>
16. , Z., Rosická, M., Kršek, M., Sulková, S., Haluzík, M., Justová, V., Lacinová, Z., Marek, J. (2005) Plasma ghrelin levels in patients with end-stage renal disease. Physiol. Res. 54, 403-408.
<https://doi.org/10.33549/physiolres.930538>
17. , S. H., Liao, Y. C., Kuo, C. L. (2008) The MTHFR 677 C/T polymorphism influences plasma levels of adhesion molecules and nitric oxide. Thromb. Res. 121, 549-554.
<https://doi.org/10.1016/j.thromres.2007.06.006>
18. , M., Zima, T., Tesař, V., Sulková, S., Fialová, L. (2003) Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int. Suppl. 84, S62-S64.
<https://doi.org/10.1046/j.1523-1755.63.s84.19.x>
19. , H., Gejyo, F., Suzuki, S., Miyazaki, R. (2000) The C677T methylenetetrahydrofolate reductase gene mutation in hemodialysis patients. J. Am. Soc. Nephrol. 11, 885-893.
<https://doi.org/10.1681/ASN.V115885>
20. , W. H., Kireta, S., Leedham, E., Russ, G. R., Coates, P. T. (2007) Uraemia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int. 72, 1138-1148.
<https://doi.org/10.1038/sj.ki.5002425>
21. , I. C. (2004) Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients? Nephrol. Dial. Transplant. 19 (Suppl. 5), V73-V78.
<https://doi.org/10.1093/ndt/gfh1060>
22. , D., Merta, M., Reiterová, J., Štekrová, J., Ryšavá, R., Obeidová, H., Viklický, O., Potměšil, P., Tesař, V. (2007) The influence of three endothelin-1 polymorphisms on the progression of IgA nephropathy. Folia Biol. (Praha) 53, 27-32.
23. , S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
<https://doi.org/10.1093/nar/16.3.1215>
24. , Y., Okamura, T., Kajinami, K., Iso, H., Imazu, A., Kawashiri, M., Mizuno, M., Takeda, Y., Sakamoto, Y., Kimura, H., Suzuki, H., Mabuchi, H. (2002) Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis 164, 321-328.
<https://doi.org/10.1016/S0021-9150(02)00105-3>
25. , L., Lindholm, B., Stenvinkel, P. (2005) End-stage renal disease – not an equal opportunity disease: the role of genetic polymorphisms. J. Intern. Med. 258, 1-12.
<https://doi.org/10.1111/j.1365-2796.2005.01516.x>
26. , L., Reiterová, J., Lněnička, P., Štekrová, J., Šafránková, H., Kohoutová, M., Tesař, V. (2012) TRPC6 gene variants in Czech adult patients with focal segmental glomerulosclerosis and minimal change disease. Folia Biol. (Praha) 58, 173-176.
27. , M., Hojker, S., Derganc, M. (2004) Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intens. Care Med. 30, 1454-1460.
<https://doi.org/10.1007/s00134-004-2307-4>
28. , B. J., Sundaram, S., Snodgrass, B., Hogan, P., King, A. J. (1996) Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients. J. Am. Soc. Nephrol. 7, 479-487.
<https://doi.org/10.1681/ASN.V73479>
29. , M., Cordido, F., Rodriguez-Carmona, A., Peteiro, J., Garcia-Naveiro, R., Garcia-Buela, J. (2004) Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol. Dial. Transplant. 19, 2095-2100.
<https://doi.org/10.1093/ndt/gfh313>
30. , P. (2001) The role of inflammation in the anaemia of end-stage renal disease. Nephrol. Dial. Transplant. 16 (Suppl 7), 36-40.
<https://doi.org/10.1093/ndt/16.suppl_7.36>
31. , L., Födinger, M., Puttinger, H., Rutkowski, P., Strozecki, P., Tyszko, S., Rutkowski, B., Horl, W. H. (2005) Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease. Am. J. Hypertens. 18, 1442-1448.
<https://doi.org/10.1016/j.amjhyper.2005.05.012>
32. , O., Ravussin, E., Jacobson, P., Pérusse, L., Rankinen, T., Tschop, M., Heiman, M. L., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., Sjostrom, L., Bouchard, C. (2002) Role of ghrelin polymorphism in obesity based on three different studies. Obes. Res. 10, 782-791.
<https://doi.org/10.1038/oby.2002.106>
33. , D., Rapa, A., Castellino, N., Bellone, S., Petri, A., Vacca, G., Aimaretti, G., Broglio, F., Bona, G. (2004) Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. Eur. J. Endocrinol. 151, 127-133.
<https://doi.org/10.1530/eje.0.1510127>
34. , C., Zimmermann, J., Schwedler, S., Metzger, T. (2002) Inflammation and cardiovascular risk in dialysis patients. Kidney Int. Suppl. 80, 99-102.
<https://doi.org/10.1046/j.1523-1755.61.s80.18.x>
35. , M. J., Gumprecht, J., Grzeszczak, W., Zukowska-Szczechowska, E. End-Stage Renal Disease Study Group. (2002) Methylenetetrahydrofolate reductase gene C677T polymorphism, plasma homocysteine and folate in endstage renal disease dialysis and non-dialysis patients. Nephron 92, 235-239.
<https://doi.org/10.1159/000064458>
